And while other options exist like dry-powder inhalers and soft mist inhalers, MDIs are still the best option for many patients for a variety of reasons, according to AstraZeneca. AstraZeneca and ...
The Powder Testing Workstation™ PTW from Copley Scientific is a robust, easy-to-use solution for assessing the flowability of powders. With its modular, customisable design, the new tester combines ...
The new capability includes clean room for compounding, fill-finish and release of non-sterile nasal sprays, and dry powders. In addition, Kenox is w ...
Kinaset Therapeutics, a clinical-stage biopharmaceutical company developing inhaled therapeutics to treat serious respiratory diseases, today announced that the United States Food and Drug ...
The electrostatic charge on a standard spacer can be decreased by priming with a puff from the inhaler (not cost-efficient), using an electrostatic coating, or washing in detergent without rinsing.
Ultrafine particle meter-dose inhalers (MDIs) have not demonstrated superior asthma control or improved safety over older MDIs. All of the inhaled corticosteroids demonstrate efficacy with once ...
A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers. Developed by Australian medtech firm ...